Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Atossa Therapeutics (ATOS) Q2 2026 Earnings
ATOS
8
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.11
-0.76
-0.4
-0.05
Details
Expected EPS
-0.99
Actual EPS
-1.11
Surprise EPS
-0.12
Surprise Percent
+12.12%
Description
Atossa Therapeutics (ATOS) has reported earnings of -1.11 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login